Qiagen N.V. (BIT:1QGEN)

Market Cap	7.74B
Revenue (ttm)	1.91B
Net Income (ttm)	80.74M
Shares Out	n/a
EPS (ttm)	0.37
PE Ratio	95.83
Forward PE	n/a
Dividend	1.23 (3.39%)
Ex-Dividend Date	Jan 28, 2025

Volume	1
Average Volume	50
Open	36.50
Previous Close	35.54
Day's Range	36.44 - 36.50
52-Week Range	35.54 - 46.40
Beta	n/a
RSI	36.70
Earnings Date	May 7, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1QGEN

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD